Formation of the human skeleton and proper bone, cartilage, joint and muscle function are determined by complex interactions between developmental signalling pathways. Genetic and acquired disorders affecting these tissues are common. The group’s research is aimed at understanding the molecular basis of these disorders to improve diagnosis and counselling, identify new therapeutic targets and test the effectiveness of new treatments to ultimately improve the quality of life for children with these debilitating conditions
Formation of the human skeleton and proper bone, cartilage, joint and muscle function are determined by complex interactions between developmental signalling pathways. Genetic and acquired disorders affecting these tissues are common. The group’s...
Formation of the human skeleton and proper bone, cartilage, joint and muscle function are determined by complex interactions between developmental signalling pathways. Genetic and acquired disorders affecting these tissues are common. The group’s research is aimed at understanding the molecular basis of these disorders to improve diagnosis and counselling, identify new therapeutic targets and test the effectiveness of new treatments to ultimately improve the quality of life for children with these debilitating conditions
Top Publications
Howden, S, Hosseini Far, H, Motazedian, A, Elefanty, AG, Stanley, EG, Lamandé, SR, Bateman, JF.
The use of simultaneous reprogramming and gene correction to generate an osteogenesis imperfecta patient COL1A1 c. 3936 G>T iPSC line and an isogenic control iPSC line..
Stem Cell Res
38:
101453
2019
view publication
Piróg, KA, Dennis, EP, Hartley, CL, Jackson, RM, Soul, J, Schwartz, J-M, Bateman, JF, Boot-Handford, RP, Briggs, MD.
XBP1 signalling is essential for alleviating mutant protein aggregation in ER-stress related skeletal disease..
PLoS Genet
15(7)
:
e1008215
2019
view publication
Hosseini Far, H, Patria, YN, Motazedian, A, Elefanty, AG, Stanley, EG, Lamandé, SR, Bateman, JF.
Generation of a heterozygous COL1A1 (c.3969_3970insT) osteogenesis imperfecta mutation human iPSC line, MCRIi001-A-1, using CRISPR/Cas9 editing..
Stem Cell Res
37:
101449
2019
view publication
Bateman, JF, Sampurno, L, Maurizi, A, Lamandé, SR, Sims, NA, Cheng, TL, Schindeler, A, Little, DG.
Effect of rapamycin on bone mass and strength in the α2(I)-G610C mouse model of osteogenesis imperfecta..
J Cell Mol Med
23(3)
:
1735 -1745
2019
view publication
Maurizi, A, Capulli, M, Curle, A, Patel, R, Ucci, A, Côrtes, JA, Oxford, H, Lamandé, SR, Bateman, JF, Rucci, N, et al.
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications..
Bone Res
7:
17
2019
view publication